Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoats Group Plc Regulatory News (COA)

Share Price Information for Coats Group Plc (COA)

Share Price is delayed by 15 minutes
Get Live Data
78.90    0.40 (0.51%)
Bid:
78.90
Ask:
79.05
Spread: 0.15 (0.19%)
Market Cap: £1.51b
COA Live PriceLast checked at - London Stock Exchange

Intraday Coats Group Plc Share Chart

Trading Statement

20 May 2026 07:00

RNS Number : 9800E
Coats Group PLC
20 May 2026
 

20 May 2026

Coats Group plc

AGM Trading Update

Robust performance year-to-date,

full-year expectations unchanged

 

Coats Group plc ('Coats' or the 'Group'), a world-leading Tier 2 supplier of critical components to the apparel and footwear industries, today announces a trading update for the four month period 1 January to 30 April 2026 (the 'period') ahead of its Annual General Meeting to be held later today.

 

Continuing operations

1st January to 30th April 2026 revenue versus same period in 2025

Organic CER

Reported

Apparel

1%

1%

Footwear

(4)%

55%

Group

(1)%

 18%

 

 

All following references are at organic constant exchange rates (CER) unless specified.

 

The Group delivered a robust performance with revenue 1% lower against a solid pre-tariff comparator period.

 

Apparel revenue was up 1%, strongly outperforming the core thread end market, driven by our key differentiators of operational agility, enduring customer relationships and our global manufacturing capabilities. The division continues to win market share across its portfolio including in China domestic and also saw strong growth in automotive thread.

 

In line with our expectations, Footwear revenue was 4% lower on an organic basis, which we estimate to be inline with industry trends, as customer caution persisted and inventory levels remained low. OrthoLite revenue was lower than the same period last year on a proforma basis against a very strong prior year comparator and temporary capacity challenges in Indonesia, where we are expanding our footprint. Our plans to realise cost synergies are on track and we are increasingly positive on sales synergies. We remain confident in OrthoLite's growth prospects.

 

Group EBIT margin was slightly higher than the same period last year, reflecting the benefits of the 2025 footprint consolidation in Footwear and the positive contribution from OrthoLite.

 

While the ongoing tensions in the Middle East have not had a material impact on trading to date, we are monitoring conditions closely. We have promptly enacted our well-honed operational and commercial playbook ensuring optimal pricing and cost discipline. We will continue to take action as required to mitigate supply chain pressures and raw material and energy cost increases.

 

Outlook

 

The Group's full year outlook remains unchanged with a modest second half profit weighting due to expected inflation cost recovery timing.

 

We expect full year free cash flow generation to remain strong, enabling the Group to continue to reduce leverage into our target range of 1-2x by year-end.

 

 

The Group will release its interim results on Tuesday 28 July 2026. 

 

 

Enquiry details

Investors

Chris Dyett

Coats Group plc

+44 (0) 7974 974 690

Media

Nick Hasell / Victoria Hayns

FTI Consulting

+44 (0)20 3727 1340

About Coats Group plc

 

Coats is a world-leading Tier 2 manufacturer and trusted partner for the apparel and footwear industries. We deliver essential materials, components, and software solutions that help our customers grow, compete and win.

 

With over 250 years of industry expertise, we're shaping the future of the apparel and footwear supply chain through insight-led innovation, impactful sustainability practices, and digital technologies that unlock better product quality, efficiency and performance.

 

Headquartered in the UK, Coats is a FTSE 250 company and a constituent of the FTSE4Good Index. In 2025, we generated $1.5 billion in revenue and employed c.19,000 people worldwide - all united by a spirit of innovation, quality and service. Learn more at www.coats.com or follow us on LinkedIn.

 

LEI: 2138003SPYWGAITNFY17

 

Cautionary statement

 

Certain statements in this trading update are forward-looking. Although the Group believes that the expectations reflected in these forward-looking statements are reasonable, we can give no assurance that these expectations will prove to have been correct. Because these statements contain risks and uncertainties, actual results may differ materially from those expressed or implied by these forward-looking statements. We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTAKCBNABKDNPD
Date   Source Headline
31st Jan 202011:10 amRNSTotal Voting Rights
8th Jan 20202:35 pmRNSBlock listing Interim Review
2nd Jan 202011:42 amRNSTotal Voting Rights
3rd Dec 201911:33 amRNSDirector/PDMR Shareholding
26th Nov 20197:00 amRNSAcquisition
22nd Nov 20197:00 amRNSTrading Statement
1st Nov 20199:13 amRNSDirector Declaration
24th Oct 20198:21 amRNSHolding(s) in Company
4th Oct 201912:40 pmRNSBlock listing Interim Review
30th Sep 20192:48 pmRNSTotal Voting Rights
27th Sep 20192:20 pmRNSHolding(s) in Company
19th Sep 20194:31 pmRNSHolding(s) in Company
30th Aug 201910:29 amRNSTotal Voting Rights
1st Aug 20197:00 amRNSHalf-year Report
31st Jul 20192:49 pmRNSTotal Voting Rights
9th Jul 20191:40 pmRNSBlock listing Interim Review
28th Jun 20192:36 pmRNSTotal Voting Rights
31st May 20193:37 pmRNSTotal Voting Rights
23rd May 20196:16 pmRNSResult of AGM
23rd May 20197:00 amRNSTrading Update
30th Apr 201911:56 amRNSTotal Voting Rights
24th Apr 201911:55 amRNSAGM Statement
5th Apr 201912:15 pmRNSBlock listing Interim Review
2nd Apr 20191:58 pmRNSTotal Voting Rights
8th Mar 201911:28 amRNSAnnual Financial Report 2018
4th Mar 20192:25 pmRNSDirector/PDMR Shareholding
4th Mar 20192:23 pmRNSDirector/PDMR Shareholding
1st Mar 20197:00 amRNS2018 Full Year Results
28th Feb 20192:59 pmRNSTotal Voting Rights
27th Feb 20191:42 pmRNSAdditional Listing
22nd Jan 20197:00 amRNSSale of North America Crafts
17th Jan 20191:48 pmRNSBlock listing Interim Review
8th Jan 20194:08 pmRNSBlock listing Interim Review
2nd Jan 201911:48 amRNSTotal Voting Rights
20th Dec 20187:00 amRNSAcquisition of ThreadSol
19th Dec 20182:39 pmRNSHolding(s) in Company
19th Dec 20187:00 amRNSAppointment of Joint Corporate Broker
4th Dec 20187:00 amRNSStrategic investment
30th Nov 201812:52 pmRNSTotal Voting Rights
20th Nov 20187:00 amRNSTrading Update
31st Oct 20181:03 pmRNSTotal Voting Rights
9th Oct 20187:01 amRNSDirector Declaration
28th Sep 20182:21 pmRNSTotal Voting Rights
31st Aug 201811:22 amRNSTotal Voting Rights
30th Aug 201811:21 amRNSHolding(s) in Company
6th Aug 201812:57 pmRNSHolding(s) in Company
31st Jul 201811:11 amRNSTotal Voting Rights
31st Jul 20187:00 amRNSHalf-year Report
6th Jul 201812:04 pmRNSBlock listing Interim Review
29th Jun 201811:07 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.